From the Journals

Metformin and AMD: Signal or Noise?

Five-year population study details 37% lower incidence of intermediate AMD in type 2 diabetic patients prescribed metformin

Share

1

Metformin linked to 37% lower intermediate AMD incidence in type 2 diabetes.
2

Study included 2,089 patients with gradable images.
3

AMD grading utilized color fundus photographs.
4

No effect on early or late AMD progression from metformin.
5

Limitations included lack of dose and adherence data.
6

Findings suggest biologically plausible protective effects.
7

Calls for prospective clinical trials to evaluate metformin's efficacy in AMD progression.